Table 1B.
Clinicopathological characteristics of 275 breast cancer patients.
| Sl no. | Characteristics | Number of patients | n (%) | ||
|---|---|---|---|---|---|
| A | Age at diagnosis | <40 | 65 | 24 | |
| 40–65 | 185 | 67 | |||
| >65 | 25 | 9 | |||
| B | Tumor grade | 1 | 4 | 1 | |
| 2 | 79 | 29 | |||
| 3 or 4 | 67 | 24 | |||
| Unknown | 125 | 45 | |||
| C | Tumor stage | 1 | 15 | 5.5 | |
| 2 | 25 | 9.1 | |||
| 3 | 50 | 18.2 | |||
| 4 | 151 | 54.9 | |||
| Unknown | 34 | 12.4 | |||
| D | Tumor type | IDC | 201 | 73.1 | |
| ILC | 2 | 0.7 | |||
| Mucinous | 1 | 0.4 | |||
| Mixed | 6 | 2.2 | |||
| DCIS | 4 | 1.5 | |||
| Unknown | 61 | 22.2 | |||
| E | Hormonal status | ||||
| HR | Positive (+) | 147 | 60.7 | ||
| HR | Her2 | Positive (+) positive (+) | 29 | 12.0 | |
| HR | Her2 | Positive (+) negative (−) | 118 | 48.8 | |
| HR | Her2 | Negative (−) positive (+) | 22 | 9.1 | |
| HR | Her2 | Negative (−) negative (−) | 73 | 30.2 | |
| HR | Her2 | Unknown | 33 | 13.6 | |
| F | Molecular subtype | Luminal A | 19 | 7 | |
| Luminal B | 93 | 34 | |||
| Basal like/TNBC | 75 | 30 | |||
| HER 2 enriched | 29 | 11 | |||
| Unknown | 61 | 22 | |||